Tirzepatide, manufactured by Eli Lilly , is different from Semaglutide because it copies two hormones instead of just one: GLP-1 (like Semaglutide), which helps control hunger and blood sugar GIP, which may help your body burn fat more efficiently and improve how it handles insulin This dual-action approach makes Tirzepatide one of the most effective new treatments for weight loss
Professor Timothy Garvey (University of Alabama at Birmingham) commented, We are encouraged by these weight loss and glycaemic control results, especially as weight loss interventions are typically less effective in patients with diabetes. This study is reviewed in more detail in Diabetes Distilled
GLP-1s have been studied and prescribed specifically for people with PCOS, and the results look encouraging
Nausea, vomiting, and abdominal discomfortcommon with GLP-1 receptor agonistscan activate the autonomic nervous system, leading to sweating as part of a vasovagal response
Within the first month, oil production begins to decrease
Heck, A